TY - JOUR
T1 - Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis
AU - Dhib-Jalbut, Suhayl
N1 - Funding Information: This supplement was supported by an educational grant from Teva Neuroscience. BioScience Communications contributed to the editorial refinement of this article and to the production of this supplement. Authors may have accepted honoraria for their supplement contributions. Funding Information: Disclosure: S.D.J. has received research grants from TEVA Pharmaceuticals. He has been a member of the Speakers' Bureau of and a Consultant to TEVA Pharmaceuticals, Berlex, and Serono.
PY - 2007/5
Y1 - 2007/5
N2 - Substantial evidence supports autoimmune activity as the etiologic mechanism underlying multiple sclerosis (MS). Both the innate and the adaptive arms of the immune system are involved in the aberrant response to several antigens associated with the myelin sheath and oligodendrocytes (OGCs) after the activation of immune cells by self- or cross-reactive microbial pathogens. The CD4 Th1 cell, in particular, has been implicated, but it is abetted by a variety of other cell types (CD8 cells, B cells, macrophages, and microglia) and soluble products (proteases, cytokines, and nitric oxide [NO]) that act both outside of and within the CNS. This review describes recent and salient findings from animal models and human clinical studies that have established our current understanding of the distinct steps in the development of immune autoreactivity that culminates in the CNS lesions associated with MS.
AB - Substantial evidence supports autoimmune activity as the etiologic mechanism underlying multiple sclerosis (MS). Both the innate and the adaptive arms of the immune system are involved in the aberrant response to several antigens associated with the myelin sheath and oligodendrocytes (OGCs) after the activation of immune cells by self- or cross-reactive microbial pathogens. The CD4 Th1 cell, in particular, has been implicated, but it is abetted by a variety of other cell types (CD8 cells, B cells, macrophages, and microglia) and soluble products (proteases, cytokines, and nitric oxide [NO]) that act both outside of and within the CNS. This review describes recent and salient findings from animal models and human clinical studies that have established our current understanding of the distinct steps in the development of immune autoreactivity that culminates in the CNS lesions associated with MS.
UR - https://www.scopus.com/pages/publications/34249803582
UR - https://www.scopus.com/pages/publications/34249803582#tab=citedBy
U2 - 10.1212/01.wnl.0000275228.13012.7b
DO - 10.1212/01.wnl.0000275228.13012.7b
M3 - Article
C2 - 17548563
SN - 0028-3878
VL - 68
SP - S13-S21
JO - Neurology
JF - Neurology
IS - 22 SUPPL. 3
ER -